Patents by Inventor Iddo Gescheit
Iddo Gescheit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10940266Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.Type: GrantFiled: August 24, 2018Date of Patent: March 9, 2021Assignee: Roche Diabetes Care, Inc.Inventors: Iddo Gescheit, Hans-Juergen Kuhr
-
Patent number: 10369281Abstract: Devices, systems and methods for adjusting fluid delivery based on past or historical fluid delivery data and/or personal parameters of a user are disclosed. Devices, and corresponding systems and methods, may comprise a dispensing unit configured to deliver a fluid from a reservoir into the body of a user and a processor having instructions operating thereon to retrieve data relating to one or more time windows from a memory, assess a correction delivery for the one or more time windows based on the data, determine a new CIR value for the one or more time windows if the correction delivery regularly follows a meal bolus and/or determine a new basal delivery profile for the one or more time windows if the correction delivery regularly precedes a meal bolus.Type: GrantFiled: September 7, 2010Date of Patent: August 6, 2019Assignee: Roche Diagnostics Operations, Inc.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20180361063Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.Type: ApplicationFiled: August 24, 2018Publication date: December 20, 2018Inventors: Iddo Gescheit, Hans-Juergen Kuhr
-
Patent number: 10080840Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.Type: GrantFiled: April 20, 2016Date of Patent: September 25, 2018Assignee: Roche Diabetes Care, Inc.Inventors: Iddo Gescheit, Hans-Juergen Kuhr
-
Patent number: 9872959Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.Type: GrantFiled: December 21, 2015Date of Patent: January 23, 2018Assignee: Roche Diabetes Care, Inc.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20160228641Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.Type: ApplicationFiled: April 20, 2016Publication date: August 11, 2016Inventors: Iddo Gescheit, Hans-Juergen Kuhr
-
Publication number: 20160106918Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.Type: ApplicationFiled: December 21, 2015Publication date: April 21, 2016Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Patent number: 9244077Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.Type: GrantFiled: June 25, 2008Date of Patent: January 26, 2016Assignee: Roche Diabetes Care, Inc.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20150157788Abstract: A therapeutic system configured for the delivery of fluid. The therapeutic system in an exemplary embodiment comprises a fluid delivery device having a fluid reservoir, an outlet port with a lumen for outputting the fluid from the reservoir, a pump for pumping the fluid through the lumen and a controller for controlling the therapeutic system. The therapeutic system may also comprise an adaptor for an infusion set, the adaptor having a plug operable for attaching to the outlet port, and wherein the adaptor also has an adaptor septum operable for being pierced by the lumen when attached to the outlet port. The therapeutic system further comprises an infusion set recognition system, wherein the controller is further operable to query the infusion set recognition system for infusion set data, wherein the infusion set data comprises an infusion set type, wherein the controller is further operable to operate the pump to provide a basal dosage of the fluid if the infusion set type is not recognized.Type: ApplicationFiled: February 18, 2015Publication date: June 11, 2015Inventors: Iddo Gescheit, Avraham Neta, Ofer Yodfat
-
Publication number: 20150151041Abstract: A transfer station for transferring a medical fluid between at least one supply container and at least one administration container of an infusion device is described. In an embodiment, the transfer station comprises at least one supply port configured for fluidic connection of the at least one supply container to the transfer station, and at least one exit port configured for fluidic connection of the at least one administration container to the transfer station. A transfer mechanism for automatically transferring a predetermined amount of medical fluid from the at least one supply container to the at least one administration container, and an electronic processing unit connected to an actuation means are provided with the transfer station. A processing unit controls the transfer mechanism and fluid transfer conditions according to a predetermined transfer demand entered by the actuation means.Type: ApplicationFiled: February 11, 2015Publication date: June 4, 2015Inventors: Ofer Yodfat, Illai J Gescheit, Iddo Gescheit
-
Patent number: 8734383Abstract: Disclosed are systems, devices, and methods, including a system that includes a processor-based device implementing at least a residual insulin (RI) determination unit configured to determine a residual insulin in the patient's body at a particular time instance based on bolus doses previously delivered to the body of the patient, each bolus dose being associated with at least one dose value and a time representative of the time that dose value was delivered to the patient's body, and based on dose dependent RI time records that each includes at least a dose value and an associated duration value representative of dose-dependent duration of therapeutic effectiveness of the associated at least the dose value. The system also includes a pump to controllably dispense the insulin from a reservoir to the body of the patient based on the residual insulin determined by the RI determination unit.Type: GrantFiled: June 23, 2010Date of Patent: May 27, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Ofer Yodfat, Iddo Gescheit, Gali Shapira
-
Patent number: 8480649Abstract: Embodiments of the present disclosure include methods, systems and devices for selecting a bolus configuration and may include one or more of providing a user interface for selection of one or more user interface elements, where each element corresponds to a bolus configuration of a drug, each element is spatially positioned within a multi-dimensional space corresponding to at least three dimensions and the element's position corresponding to each dimension.Type: GrantFiled: April 28, 2009Date of Patent: July 9, 2013Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Patent number: 8454510Abstract: A system and a method for determining an assessed carbohydrate to insulin ratio of a patient is described. The system and the method can comprise a memory component adapted for storing an initial set of values comprising at least one of a blood glucose level, a target blood glucose level, an insulin sensitivity, and, an estimated carbohydrate to insulin ratio. The system and the method can also comprise a bolus selection component adapted for selecting a test bolus corresponding to the determined initial set of values and a planned meal. In one implementation, the bolus selection component can receive bolus dose input from a user. In another implementation, the bolus selection component can estimate the bolus dose using a set of available inputs (e.g. the amount of carbohydrates in the planned meal). The system and the method can further comprise a user interface component adapted for receiving a confirmation that the test bolus has been administered to the patient.Type: GrantFiled: June 20, 2008Date of Patent: June 4, 2013Assignee: Medingo Ltd.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20120226259Abstract: Devices, systems and methods for adjusting fluid delivery based on past or historical fluid delivery data and/or personal parameters of a user are disclosed. Devices, and corresponding systems and methods, may comprise a dispensing unit configured to deliver a fluid from a reservoir into the body of a user and a processor having instructions operating thereon to retrieve data relating to one or more time windows from a memory, assess a correction delivery for the one or more time windows based on the data, determine a new CIR value for the one or more time windows if the correction delivery regularly follows a meal bolus and/or determine a new basal delivery profile for the one or more time windows if the correction delivery regularly precedes a meal bolus.Type: ApplicationFiled: September 7, 2010Publication date: September 6, 2012Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20120220939Abstract: Disclosed are systems, devices, and methods, including a system that includes a processor-based device implementing at least a residual insulin (RI) determination unit configured to determine a residual insulin in the patient's body at a particular time instance based on bolus doses previously delivered to the body of the patient, each bolus dose being associated with at least one dose value and a time representative of the time that dose value was delivered to the patient's body, and based on dose dependent RI time records that each includes at least a dose value and an associated duration value representative of dose-dependent duration of therapeutic effectiveness of the associated at least the dose value. The system also includes a pump to controllably dispense the insulin from a reservoir to the body of the patient based on the residual insulin determined by the RI determination unit.Type: ApplicationFiled: June 23, 2010Publication date: August 30, 2012Applicant: Medingo Ltd.Inventors: Ofer Yodfat, Iddo Gescheit, Gali Shapira
-
Publication number: 20120109047Abstract: Disclosed is a system to deliver insulin to a user's body. The system includes a dispensing unit to deliver the insulin to the body, and a control mechanism to control delivery of basal insulin according to a predetermined basal infusion pattern, the basal infusion pattern selected from a plurality of predetermined basal infusion patterns. In some embodiments, selection of the basal infusion pattern may be based on one or more personal characteristics of the user.Type: ApplicationFiled: December 30, 2011Publication date: May 3, 2012Applicant: Medingo, Ltd.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Patent number: 8088098Abstract: Disclosed is a system to deliver insulin to a user's body. The system includes a dispensing unit to deliver the insulin to the body, and a control mechanism to control delivery of basal insulin according to a predetermined basal infusion pattern, the basal infusion pattern selected from a plurality of predetermined basal infusion patterns. In some embodiments, selection of the basal infusion pattern may be based on one or more personal characteristics of the user.Type: GrantFiled: June 25, 2008Date of Patent: January 3, 2012Assignee: Medingo, Ltd.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20110118699Abstract: Methods, systems and devices for sustained medical infusion of fluids are described. Some implementations describe portable infusion methods, systems and devices for selecting a pattern of fluid delivery. Some implementations describe skin securable insulin dispensing methods, systems and devices for selecting a delivery pattern according to the nutritional characteristics (e.g. glycemic index, GI, fat content, etc.) of caloric intake of the user.Type: ApplicationFiled: April 28, 2009Publication date: May 19, 2011Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20110106050Abstract: Embodiments of the present disclosure include methods, systems and devices for selecting a bolus configuration and may include one or more of providing a user interface for selection of one or more user interface elements, where each element corresponds to a bolus configuration of a drug, each element is spatially positioned within a multi-dimensional space corresponding to at least three dimensions and the element's position corresponding to each dimension.Type: ApplicationFiled: April 28, 2009Publication date: May 5, 2011Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
-
Publication number: 20080319384Abstract: Disclosed is a system to deliver insulin to a user's body. The system includes a dispensing unit to deliver the insulin to the body, and a control mechanism to control delivery of basal insulin according to a predetermined basal infusion pattern, the basal infusion pattern selected from a plurality of predetermined basal infusion patterns. In some embodiments, selection of the basal infusion pattern may be based on one or more personal characteristics of the user.Type: ApplicationFiled: June 25, 2008Publication date: December 25, 2008Applicant: Medingo, Ltd.Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit